188 results on '"Rossi, Davide"'
Search Results
2. SOHO State of the Art Updates and Next Questions | Treatment of Richter's Transformation
3. SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma
4. Genetic and phenotypic attributes of splenic marginal zone lymphoma
5. Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab
6. Co-occurrence and mutual exclusivity: what cross-cancer mutation patterns can tell us
7. Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
8. Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1
9. Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial
10. Copanlisib synergizes with conventional and targeted agents including venetoclax in B- and T-cell lymphoma models
11. HL-370 Fragmentóme Profiling Reveals Distinct Molecular Subgroups of Classic Hodgkin Lymphoma
12. Biology and treatment of Richter syndrome
13. Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
14. Capturing and managing knowledge using social software and semantic web technologies
15. Diffuse large B-cell lymphoma genotyping on the liquid biopsy
16. The genetics of nodal marginal zone lymphoma
17. Splenic marginal zone lymphoma: from genetics to management
18. Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations
19. The Effect of Psychological Intervention on Thirst and Interdialytic Weight Gain in Patients on Chronic Hemodialysis: A Randomized Controlled Trial
20. Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8
21. DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features
22. Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia
23. Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness
24. Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia
25. Genomic profiling for clinical decision making in lymphoid neoplasms
26. Clonal Evolution of Chronic Lymphocytic Leukemia with Bimodal CD49d Expression Reveals CD49d Plasticity
27. A Comprehensive DNA Methylome Analysis of Stereotyped and Non-Stereotyped CLL Reveals an Epigenetic Signature with Strong Clinical Impact Encompassing IGHV Status, Stereotypes and IGLV3-21R110
28. Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study
29. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome
30. Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia
31. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia
32. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation
33. The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma
34. Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
35. Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia
36. First-Line Venetoclax Combinations in Fit Patients with CLL: 4-Year Follow-up and NGS-Based MRD Analysis from the Phase 3 GAIA/CLL13 Trial
37. EXABS-154-CLL Biology of Richter's Transformation
38. CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?
39. 521 - Zuma-25: A Phase 2 Study of Brexucabtagene Autoleucel (KTE-X19) Chimeric Antigen Receptor T-Cell Therapy in Adult Patients with Relapsed/Refractory Rare B-Cell Malignancies
40. Clonal Evolution in Chronic Lymphocytic Leukemia
41. Mechanisms of resistance to venetoclax
42. Real-World Effectiveness and Safety of Venetoclax in Combination with Obinutuzumab in Treatment-Naive CLL Patients - Data from the Observational Study Verve
43. PI3K and BTK Inhibition Induces the Upregulation of CD19 and Increases Sensitivity to CAR T Cells in a Model of Marginal Zone Lymphoma (MZL)
44. The CXCR4dim/CD5bright Proliferative Fraction Reappears in Relapsed CLL Under Ibrutinib, Enriched in BTK Mutations
45. Single Cell RNA-Seq of Extranodal Marginal Zone Lymphoma (MZL) Identifies Site-Specific and Shared Features in Both B and T Cell Components
46. Molecular Clustering on Ctdna May Improve Prognostic Stratification of DLBCL Patients
47. Viral cfDNA Profiling Reveals Distinct EBV Subtypes and Stratifies Risk in Hodgkin Lymphomas
48. Distinct Molecular Subtypes of Classic Hodgkin Lymphoma Identified By Comprehensive Noninvasive Profiling
49. MRD-Negativity As a Potential Surrogate Endpoint after Frontline DLBCL Therapy: Pooled Analysis of Trials & Implications for Clinical Trial Design
50. Molecular histogenesis of posttransplantation lymphoproliferative disorders
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.